Independent register of U.S. FDA drug recalls · updated Oct 11, 2026
RxRecalls Get alerts

Class II drug recalls - moderate risk

Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.

14,535 recalls, newest first.

Class II · Moderate risk

ROPivacaine HCl 0.2% PF in Sodium Chloride 1

STAQ Pharma Inc. received consumer complaints related to leaking bags and other potential bag concerns. Upon investigation, they determine the source of the issue was with the bag manufacturer who released bags Lot # 134142-001A which had failed internal QC tests for leaks.

Completed Failed specification STAQ Pharma, Inc. NDC 73177-0109-26 D-0147-2024
Class II · Moderate risk

PAROXETINE tablets

Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine

Terminated Impurity / degradation Golden State Medical Supply Inc. NDC 60429-737-30 D-0130-2024
Class II · Moderate risk

PAROXETINE tablets

Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine

Terminated Impurity / degradation Golden State Medical Supply Inc. NDC 60429-735-90 D-0129-2024
Class II · Moderate risk

PAROXETINE tablets

Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine

Terminated Impurity / degradation Golden State Medical Supply Inc. NDC 60429-734-30 D-0128-2024

Recalls by year